Deferasirox, an oral iron chelator, prevents hepatocarcinogenesis and adverse effects of sorafenib

Although sorafenib is expected to have a chemopreventive effect on hepatocellular carcinoma (HCC) recurrence, there are limitations to its use because of adverse effects, including effects on liver function. We have reported that the iron chelator, deferoxamine can prevent liver fibrosis and preneop...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Clin Biochem Nutr
Main Authors: Yamamoto, Naoki, Yamasaki, Takahiro, Takami, Taro, Uchida, Koichi, Fujisawa, Koichi, Matsumoto, Toshihiko, Saeki, Issei, Terai, Shuji, Sakaida, Isao
Format: Artigo
Sprog:Inglês
Udgivet: the Society for Free Radical Research Japan 2016
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4865599/
https://ncbi.nlm.nih.gov/pubmed/27257345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3164/jcbn.15-127
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker